Cruciferous Sprouts (Broccoli Sprouts) for Cancer Risk Reduction

Research suggests that cruciferous sprouts, particularly broccoli sprouts and their active compounds such as sulforaphane, may play a role in reducing cancer risk through several biological mechanisms, including reducing oxidative DNA damage, activating protective cellular enzymes, influencing epigenetic gene regulation, and inhibiting tumor cell growth in laboratory and animal models. The evidence base includes a small randomized controlled trial showing a 28% reduction in a urinary marker of DNA damage following cruciferous vegetable consumption, a human dietary intervention demonstrating reduced DNA damage in blood cells after sprout consumption, multiple laboratory and animal studies showing anti-tumor effects against prostate and bladder cancer cells, and reviews discussing the potential of indole-3-carbinol and isothiocyanates in breast cancer chemoprevention contexts. Studies are generally supportive in direction, though the majority of mechanistic findings come from cell culture and animal studies, with limited large-scale human trials to confirm these effects in living people across varied populations and cancer types. The research is considered preliminary and promising rather than conclusive, and further clinical trials are needed before any firm conclusions can be drawn about the magnitude or reliability of cancer risk reduction in humans.